New hope for transplant patients: experimental drug aims to stop rejection
Disease control
Not yet recruiting
This study is testing a new drug called TNX-1500 in five people who receive a kidney transplant. The goal is to see if the drug is safe and can help prevent the body's immune system from attacking and rejecting the new kidney. Researchers will monitor patients for a year to check…
Phase: PHASE2 • Sponsor: Ayman Al Jurdi, MD • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC